A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular Carcinoma
Clinical trial NCT01897038 · COMPLETED
Trial details
- NCT number
- NCT01897038
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.